ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

NCT03408405 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawal of funding from primary sponsor

Conditions

Steroid-Resistant Nephrotic Syndrome

Interventions

DRUG: Acthar Gel 80 UNT/ML Injectable Solution

Sponsor

Rhode Island Hospital

Collaborators

[object Object]
[object Object]
[object Object]